Sensei Biotherapeutics Inc (SNSE) Stock Price, Quote & News

Company Profile

Sensei Biotherapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company's Tumor Microenvironment Activated Biologics platform is designed to generate highly selective therapeutics that disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. It also offers Solnerstotug, an active monoclonal antibody that is in clinical Phase 1/2 targeting the immune ch...

Industry: Biotechnology

Sector: Healthcare

Phone: 240 243 8000

Website: www.senseibio.com

Address:

1405 Research Boulevard, Suite 125, Rockville, United States

mmqwerty00 Aug. 22 at 6:16 PM

$SNSE Was in heavy here in May 2024 and got absolutely pummeled. Always thought the data was solid and didn't get the destruction of value here. Bought back in here heavy...hoping not flying too close to the sun here ahead of October data. Have a feeling...and maybe I'm a moron...but I think this go around is going to be significantly better than 18 months ago

1 · Reply

ibaian Aug. 22 at 4:57 AM

$SNSE $20 potential, low float pharma

0 · Reply

ZoroSwings Aug. 16 at 8:08 PM

🚨TGL🚨 --->Treasure Global, On High Squeeze Watch! This low float (2.7M) Crypto stock setting up to be the next 200%+ runner as BTC/ETH at all time highs. -Multiple upcoming catalyst. trading well under book value here and a crypto treasury play with BTC and ETH. $RVPH $KPSRX $PSTV $SNSE

0 · Reply

topstockalerts Aug. 15 at 5:28 PM

Top Gainers PT2 $MTNB $FOSL $XNET $UFG $SNSE

0 · Reply

littlestash Aug. 15 at 4:06 PM

$SNSE making moves

0 · Reply

GuyFawkes_EOD Aug. 15 at 1:39 PM

$SNSE halted 🤔

0 · Reply

Thunder000 Aug. 13 at 3:00 PM

$CGTX $HOTH $MIRA $SNSE Please consider come join $IBRX after you’ve done here. Great news and way way undervalued “ImmunityBio Reports Complete Responses in Non-Hodgkin Waldenstrom Lymphoma Patients with Chemotherapy-Free, First-In-Class CD19 CAR-NK Immunotherapy”

1 · Reply